The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use

Abstract

Generic medicines are clinically interchangeable with original brand medicines and have the same quality, efficacy and safety profiles. They are, nevertheless, much cheaper in price. Thus, while providing the same therapeutic outcomes, generic medicines lead to substantial savings for healthcare systems. Therefore, the quality use of generic medicines is promoted in many countries. In this paper, we reviewed the role of generic medicines in healthcare systems and the experiences of promoting the use of generic medicines in eight selected countries, namely the United States (US), the United Kingdom (UK), Sweden, Finland, Australia, Japan, Malaysia and Thailand. The review showed that there are different main policies adopted to promote generic medicines such as generic substitution in the US, generic prescribing in the UK and mandatory generic substitution in Sweden and Finland. To effectively and successfully implement the main policy, different complementary policies and initiatives were necessarily introduced. Barriers to generic medicine use varied between countries from negative perceptions about generic medicines to lack of a coherent generic medicine policy, while facilitators included availability of information about generic medicines to both healthcare professionals and patients, brand interchangeability guidelines, regulations that support generic substitution by pharmacists, and incentives to both healthcare professionals and patients.

Bioequivalence of Generic Drugs: A Simple Explanation for a US Food and Drug Administration Requirement

“…Other articles discuss the merits and demerits of generic and branded drugs [6][7][8][9] ; here, the reader's attention is drawn to 2 points that are not commonly considered:…”

Knowledge, Attitude and Practice of Resident Doctors for use of Generic Medicines at a Tertiary care Hospital

“…However, these are comparable in efficacy and safety as brand medicines, so they provide quality care at an affordable cost. 4 Generic medicines are important to reduce the healthcare expenditure particularly in developing countries. In India, generic medicines are approved under the guidelines of Central Drug Standard Control Organization (CDSCO), which requires submission of information regarding administrative and prescribing information, product quality, nonclinical as well as clinical study reports.…”

Untitled

“…It has been estimated that switching procurement from branded drugs to the lowest-priced generic equivalents in the private sector in 17 developing countries could result in an average of 60% cost savings 3 , the generic substitution is mandatory in many European countries like Sweden, Germany, Norway, France, Finland, Spain, and permissive in others like Portugal, Denmark, Italy, Poland, Czech Republic, The Netherlands, Hungary, Poland, Latvia 4 , while in USA, generic substitution is a common practice with pharmacists substituting up to 84% of brand drug prescriptions 5 . After, the UK, Finland, Greek and other governments introduced generic prescribing, Govt.…”